ロード中...

In Vitro Activity of Aztreonam-Avibactam against Enterobacteriaceae and Pseudomonas aeruginosa Isolated by Clinical Laboratories in 40 Countries from 2012 to 2015

The combination of the monobactam aztreonam and the non-β-lactam β-lactamase inhibitor avibactam is currently in clinical development for the treatment of serious infections caused by metallo-β-lactamase (MBL)-producing Enterobacteriaceae, a difficult-to-treat subtype of carbapenem-resistant Enterob...

詳細記述

保存先:
書誌詳細
出版年:Antimicrob Agents Chemother
主要な著者: Karlowsky, James A., Kazmierczak, Krystyna M., de Jonge, Boudewijn L. M., Hackel, Meredith A., Sahm, Daniel F., Bradford, Patricia A.
フォーマット: Artigo
言語:Inglês
出版事項: American Society for Microbiology 2017
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5571336/
https://ncbi.nlm.nih.gov/pubmed/28630192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00472-17
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!